Health

Centers for Medicare & Medicaid Services Issues New Code for Encala®

September 1, 2021

Envara Health, a company committed to making significant advancements in the field of clinical nutrition, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a new Healthcare Common Procedure Coding System (HCPCS) code for Encala®, a structured lipid matrix powder for oral administration. This decision establishes the S9432 code, “Medical Food […]

Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV

August 30, 2021

Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced that the Temple University team collaborating with Excision on a project, CRISPR for Cure, has received a Martin Delaney Grant from the National Institutes of Health (NIH) of $4.8 million on an annual basis for the next five years […]

Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in Healthcare

August 27, 2021

Biomeme, the leading provider of portable PCR testing solutions, has signed a definitive agreement to acquire Predigen, a privately held diagnostic company and emerging leader in precision medicine focused on host response diagnostics. Predigen’s acquisition will expand Biomeme’s capabilities across infectious disease and clinical microbiology, business management, and commercialization. redigen’s portfolio includes flagship host gene […]

Navrogen Announces The Closing Of $3.2M Funding To Support Its Humoral Immuno-Oncology Platform Discovery Technologies And Preclinical Pipeline

August 10, 2021

Navrogen, Inc. announced today that it has raised $3.2M in convertible note financing to support its operations, Humoral Immuno-Oncology (HIO) discovery platform and preclinical therapeutic pipeline activities. The financing was led by Ben Franklin Technology Partners of South Eastern Pennsylvania and a number of private investors. Previous clinical studies have confirmed that tumors produce immune […]

E-stethoscope Developer Strados Labs Raises $1.93M From Private Stock Sale

August 6, 2021

Philadelphia medical device developer Strados Labs raised $1.93 million in a private stock sale. Strados founder and CEO Nicholas Delmonico could not be reached for comment on the company’s plans for the funds. The financing was disclosed in documents the company filed with the Securities and Exchange Commission. In December, Strados received Food and Drug […]

These Philly Startups Were Accepted into Y Combinator’s Summer 2021 Cohort

July 13, 2021

Two Philadelphia-based startups are participating in the prominent Silicon Valley accelerator Y Combinator this summer for its second summer of virtual sessions running from June through August. Therapeutics company SFA Therapeutics, Inc. and AI-based customer-facing calls startup q&ai joined the summer 2021 batch. This summer session includes 152 companies from five continents, and startups offering […]

Cagent Vascular Receives $9M Investment to Accelerate Marketing of its Lead Product

June 22, 2021

A Wayne medical device company has raised $9 million to accelerate the commercialization of its peripheral artery disease device cleared by the Food and Drug Administration last year. Cagent Vascular received the investment from Sectoral Asset Management. Marc-Andre Marcotte, a partner and COO at the Canadian investment firm, has joined Cagent’s board of directors. Founded […]

11 Philly Tech Leaders Shaping the Future

June 18, 2021

Philadelphia continues to build on a legacy of intellectual innovation. Meet the technology thought leaders shaping our city—and the world. Dr. Subha Airan-Javia, Founder and CEO, CareAlign After spending 11 years as a healthcare information technology physician, Dr. Subha Airan-Javia began to notice the gaps and barriers impeding the clinical workflow. One of the biggest […]

PolyCore Therapeutics Awarded Supplemental NINDS Grant to Understand the Effects of its Lead Compound, PCT-3012, to Treat Cognitive Impairment in Alzheimer’s disease

May 17, 2021

PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders, today announced that it has been awarded a $456,000 Phase II SBIR supplemental grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) to fund research of […]

Temple Spinout ExpressCells Adds New Investors to Meet ‘Rapidly Growing Demand’

April 12, 2021

ExpressCells, a gene editing technology company spun out of Temple University, has raised $590,500 in an equity financing. Founded in 2018, ExpressCells is using its own proprietary genome editing technology in combination with CRISPR to create advanced “knock-in” cell lines to enhance drug discovery and support other types of biological research. The speed of the […]